Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samba-02: Dance-501 PK/PD in T2DM
NCT02716610Phase 2Completed
- Sponsor
- Aerami Therapeutics
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of Dance-501 in type 2 diabetes mellitus (T2DM), sponsored by Aerami Therapeutics. Started Oct 2013; status: completed.
02
Drugs
Dance-501
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02716610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02716610.